Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G3KY
|
|||
Drug Name |
PMID25416646-Compound-Figure2-K
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
INTEKRIN THERAPEUTICS, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H12Cl4N2O3S
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl
|
|||
InChI |
1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H
|
|||
InChIKey |
NMRWDFUZLLQSBN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 315224-26-1
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | PPAR ligands and their therapeutic applications: a patent review (2008 - 2014).Expert Opin Ther Pat. 2015 Feb;25(2):175-91. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.